Sulphate metabolism in autism


Normal biochemistry

This is a complex subject in which the sulphate ion can be both produced in the body through biochemical formation (generally from methionine and cysteine aminoacids) and absorbed from the gut. 

 

It is transported across membranes by various transporter protein molecules, which are found almost universally in the body.  The ion is activated into PAPS (adenosine 3’-phosphate 5’-sulphatophosphate) which is a donor molecule to cause the sulphation through the formation of an ester. 

 

This causes the formation of highly soluble molecules that are good for urinary or biliary elimination.  The body also forms heparans and glycans using PAPS in a complex method.  

 

In the gut sulphate is absorbed in the small intestine through deliberate transporter molecules, about which little is known concerning their regulation.   In an adult the whole body inorganic sulphate turnover is represented by the 841 +/- 49 micromol/hr and average urinary inorganic sulphate excretion is around 600 micromol/hr. Following injection of sulphate into the body around 50% is excreted as esters and whole body sulphation accounted for around 27%  of inorganic sulphate turnover.  Exracellular inorganic sulphate is an important pool for intracellular sulphation.

Sulphate in autism

It should be noted that sulphate, because of its interaction with cysteine and methionine formation must be viewed with the formation of other sulphur containing compounds e.g. glutathione and oxidative stress

Glycosaminoglycans in autism

We do know that these compounds (like heparin, and chondroitin sulphate, and the glycosaminoglycans that are present in large amounts in the basal membranes of the gut, kidney and skin) may well be modified but the research in this respect is missing from major literature. 

 

 

formula of heparinetal

 

Glycosaminoglycans are long chains of sugar molecules with sulphate modification of some of the ester linked elements.  They can be variants and vary dramatically in the amount of sulphate depending on the amount of sulphate available when they are being made.

 

Normal sulphate biology

It is probably a good idea to read through one of these simply to get a grip on how sulphates are formed, taken in from the gut, and excreted.  They may also be created through specific biological mechanisms that are altered in ASD.

 

Markovich D.  Physiological role and regulation of mammalian sulfate transporters.  Physiological reviews.  2001;81:1499-1533. also see: Cole D, Evrosvski J.  The clinical chemistry of inorganic sulfate. Crit Rev Clin Lab Sci 2000 37(4);299-44. Also see: Hoffer LJ et al.  Human sulfate kinetics.  Am J Physiol Regul Integr Comp Physiol 2005;289;R1372-80.

 

Hoffer LJ, Hamadeh MJ, Robitaille L, Norwich KH. Human sulfate kinetics. Am J Physiol Regul Integr Comp Physiol. 2005 Nov;289(5):R1372-80. Epub 2005 Jul 28.

 

Cole DE, Evrovski J.  The clinical chemistry of inorganic sulfate.  Crit Rev Clin Lab Sci. 2000 Aug;37(4):299-344.

 


Alterations seen in autism

 

McFadden SA.Toxicology.

 Phenotypic variation in xenobiotic metabolism and adverse environmental response: focus on sulfur-dependent detoxification pathways. 1996 Jul 17;111(1-3):43-65.  (autism only used as an example in the impaired sulphation of xenobiotic compounds)

 

Alberti A, Pirrone P, Elia M, Waring RH, Romano C. Sulphation deficit in "low-functioning" autistic children: a pilot study. Biol Psychiatry. 1999 Aug 1;46(3):420-4. (also found low levels of sulphotransferase in platelets and low plasma sulphate).

Urinary increased sulphate (inorganic, organic), sulphite, thiocyanite (by about 50%) in autism vs control.  Also d-glucaric acid was very high, which is also used as a modifier for toxins.  Original source is not clear. This is quoted under Adams work, who is clearly wanting to press ahead with sulphate research.   

 

Waring RH, Klovrza LV.  Sulphur metabolism in autism.  J Nutritional and Environmental Medicine 2000;1:25-32 (Urinary excretion of sulphate sulphate, thiocyanate and thiosulphate were measured in 232 autistic children and compared with 68 controls.  Significantly higher excretion was seen in all of these compounds except thiocyanate).

Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA. Am J Clin Nutr. 2004 Dec;80(6):1611-7.  Relative to the control children, the children with autism had significantly lower baseline plasma concentrations of methionine, SAM, homocysteine, cystathionine, cysteine, and total glutathione and significantly higher concentrations of SAH, adenosine, and oxidized glutathione. This metabolic profile is consistent with impaired capacity for methylation (significantly lower ratio of SAM to SAH) and increased oxidative stress (significantly lower redox ratio of reduced glutathione to oxidized glutathione) in children with autism. The intervention trial was effective in normalizing the metabolic imbalance in the autistic children.

 

Geier DA, Geier MR. A clinical and laboratory evaluation of methionine cycle-transsulfuration and androgen pathway markers in children with autistic disorders. Horm Res. 2006;66(4):182-8. (this has been followed up by several groups but nobody has found the reason or prevalence behind it.  The effect it would  have on the androgen pathways is also unclear)

 

Waring RH, Ngong JM, Klovrza L, Green S, Sharp H.  Biochemical parameters in autistic children.  Dev Brain Dystunction 1997;10:40-43.  (a short review, particularly showing the changes in autism)

 

Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Geier MR. A Prospective Study of Transsulfuration Biomarkers in Autistic Disorders. Neurochem Res. 2008 Jul 9.  (Participants diagnosed with ASDs had significantly (P < 0.001) decreased plasma reduced glutathione, plasma cysteine, plasma taurine, plasma sulfate, and plasma free sulfate relative to controls. By contrast, participants diagnosed with ASDs had significantly (P < 0.001) increased plasma oxidised glutathione relative to controls..  Full article at:  A prospective study of transsulfuration biomarkers in autistic disorders. Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Geier MR. Neurochem Res. 2009 Feb;34(2):386-93. Epub 2008 Jul 9. Erratum in: Neurochem Res. 2009 Feb;34(2):394

 

Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. James SJ, Melnyk S, Jernigan S, Cleves MA, Halsted CH, Wong DH, Cutler P, Bock K, Boris M, Bradstreet JJ, Baker SM, Gaylor DW. Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):947-56  Plasma levels of metabolites in methionine transmethylation and transsulfuration pathways were measured in 80 autistic and 73 control children. In addition, common polymorphic variants known to modulate these metabolic pathways were evaluated in 360 autistic children and 205 controls. The metabolic results indicated that plasma methionine and the ratio of S-adenosylmethionine (SAM) to S-adenosylhomocysteine (SAH), an indicator of methylation capacity, were significantly decreased in the autistic children relative to age-matched controls. In addition, plasma levels of cysteine, glutathione, and the ratio of reduced to oxidized glutathione, an indication of antioxidant capacity and redox homeostasis, were significantly decreased.  The group is putting these over as potentially being associated with genetic changes but they are not carrying out the isolation of the isolation of the genes past some specific ones.   Differences in allele frequency and/or significant gene-gene interactions were found for relevant genes encoding the reduced folate carrier (RFC 80G > A), transcobalamin II (TCN2 776G > C), catechol-O-methyltransferase (COMT 472G > A), methylenetetrahydrofolate reductase (MTHFR 677C > T and 1298A > C), and glutathione-S-transferase (GST M1).

 

One Carbon Metabolism Disturbances and the C667T MTHFR Gene Polymorphism in Children with Autism Spectrum Disorders. Paşca SP, Dronca E, Kaucsár T, Craciun EC, Endreffy E, Ferencz BK, Iftene F, Benga I, Cornean R, Banerjee R, Dronca M. J Cell Mol Med. 2008 Aug 9.   This is an attempt to see if there is an association between the genes of the trans-sulfuration pathways, and various other pathways involving B12, and methionine cycle may be altered in children with ASD.   No metabolic disturbances were seen in the Aspergers patients, while in the autistic and PDD-NOS groups, lower plasma levels of methionine (P=0.01 and P=0.03, respectively) and alpha-aminobutyrate were observed (P=0.01 and P=0.001, respectively). Only in the autistic group, plasma cysteine (P=0.02) and total blood glutathione (P=0.02) were found to be reduced.   They did not find a statistical difference in the genetics of the cases but felt that a change in the one carbon metabolism may have altered.

Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. James SJ, Melnyk S, Fuchs G, Reid T, Jernigan S, Pavliv O, Hubanks A, Gaylor DW. Am J Clin Nutr. 2009 Jan;89(1):425-30. The results indicated that pretreatment metabolite concentrations in autistic children were significantly different from values in the control children. The 3-mo intervention with methyl cobalamine and folinic acid resulted in significant increases in cysteine, cysteinylglycine, and glutathione concentrations (P < 0.001).  The significant improvements observed in transmethylation metabolites and glutathione redox status after treatment suggest that targeted nutritional intervention with methylcobalamin and folinic acid may be of clinical benefit in some children who have autism.  In other words they also found a difference in the ability of the child’s metabolism to modify the pathways but that methylcobalamine and folate can make a major difference to this.   For a better explanation of this see page on cobalamine. 

 

 

Associations with other sulphur molecules

 

Whiteley, P, Waring R, Shattock P, Hooper M.  Correlation of urinary exretion of cysteine – sulphate metabolites and trans-indolyl-3-3acryloylglicine in 10 children diagnosed with pervasive developmental disorders.  Durham conference proceedings 2004.  This shows a relationship between IAG and urinary cysteine but with little else. 

 

Waring R, Klovrza L. Sulphur metabolism in autism. J Nutr Envir Med 10;25-32 2000.  (Ros Waring is particularly interested in cysteine dioxidase as a limiting enzyme in the internal production of sulphate.  She realises that the requirement of sulphate may be dramatically higher in autism than cysteine dioxidase can supply). 

Abnormal transmethylation/transsulfuration metabolism and DNA hypomethylation among parents of children with autism. James SJ, Melnyk S, Jernigan S, Hubanks A, Rose S, Gaylor DW. J Autism Dev Disord. 2008 Nov;38(10):1966-75. Epub 2008 May 30. Erratum in: J Autism Dev Disord. 2008 Nov;38(10):1976. Jill James, S.  Recent evidence suggests that some autistic children may have reduced detoxification capacity and may be under chronic oxidative stress. Based on reports of abnormal methionine and glutathione metabolism in autistic children, it was of interest to examine the same metabolic profile in the parents. The results indicated that parents share similar metabolic deficits in methylation capacity and glutathione-dependent antioxidant/detoxification capacity observed in many autistic children.  At this point they had not found whether it is due to a genetic change or not.

A mathematical model of glutathione metabolism. Reed MC, Thomas RL, Pavisic J, James SJ, Ulrich CM, Nijhout HF. Theor Biol Med Model. 2008 Apr 28;5:8.  We show that the glutathione pools in hepatic cells and in the blood are quite insensitive to fluctuations in amino acid input and offer an explanation based on model predictions. In contrast, we show that hepatic glutathione pools are highly sensitive to the level of oxidative stress. The model shows that overexpression of genes on chromosome 21 and an increase in oxidative stress can explain the metabolic profile of Down syndrome. The model also correctly simulates the metabolic profile of autism when oxidative stress is substantially increased and the adenosine concentration is raised. Finally, we discuss how individual variation arises and its consequences for one-carbon and glutathione metabolism. 

 

 

 

Glycosaminoglycans

These are compounds as indicated as above with long chains of disaccharides (as shown), possibly with molecular weights of over 5000.  They make up important parts of basal membranes and the borders between tissues. The large amounts of sulphate on the surface of the molecules makes them exceptionally soluble and interact precisely with sites on cells.  They are not penetrable into the brain.

 

van der Kraan PM, de Vries BJ, Vitters EL, van den Berg WB, van de Putte LB.  The effect of low sulfate concentrations on the glycosaminoglycan synthesis in anatomically intact articular cartilage of the mouse.  J Orthop Res. 1989;7(5):645-53. (this would suggest that the relatively low sulphate levels seen in autism may modify the glycosaminoglycans).

 

Murch SH, MacDonald TT, Walker-Smith JA, Levin M, Lionetti P, Klein NJ. Disruption of sulphated glycosaminoglycans in intestinal inflammation. Lancet 341:711–741, 1993.  (although this has been demonstrated by Murch in other IBDs, all that seems to have been shown in autism is that there  is a thickening of the basal membrane in the autistic gut biopsies and this has not been published)

 

 

Non sourced data:

 

Sulphation low in 15 of 17 (mean 5 vs. nl 10-18) Glutathione Conjugation low in 14 of 17 (mean 0.55 vs 1.4-2.9)  Glucuronidation low in 17 of 17 (mean 9.6 vs. 26.0-46.0) Glycine Conjugation low in 12 of 17 (15.4 vs. 30.0-53.0)

 

Return to home page